Store
Mergers and Acquisitions in the IVD Market, 2016-2019
Publication Date: June 25, 2019
Tags: Diagnostic Instruments, Funding and Investments, In Vitro Diagnostics (IVD), Mergers and Acquisitions (M&A)
Pages: 100
SKU: 19-043
In vitro diagnostic (IVD) products continue to experience robust sales growth across various categories, driven by new product innovations, global health spending shifts, regulatory changes, and evolving disease trends. In this dynamic market, companies are strategically acquiring new assets to enhance their revenue streams and foster product innovation. Kalorama Information’s latest report, Mergers and Acquisitions in the IVD Market, 2016-2019, details over 220 acquisitions in the diagnostics industry from 2016 to June 2019, offering a comprehensive look at the landscape of market transactions.
Report Highlights:
- Market Dynamics:
- The IVD market is constantly evolving with new products, regulatory changes, and shifts in global health spending.
- Strategic acquisitions are a key growth strategy for companies, providing both revenue and innovation boosts.
- Key Growth Segments:
- Next-Generation Sequencing (NGS): Driving precision medicine with advanced genomic technologies.
- Cancer Testing (Liquid Biopsy): Transforming cancer diagnostics with minimally invasive tests.
- Companion Diagnostics: Enhancing personalized treatment approaches with targeted diagnostics.
- Major Players and Activities:
- Detailed analysis of mergers and acquisitions involving leading companies, including Roche, Abbott, and Danaher.
- Insights into significant transactions and their market impacts.
- Detailed Acquisitions Listings:
- Selected Acquisitions of Diagnostic Companies, 2018 to June 2019
- Selected Acquisitions of Diagnostic Companies, 2016-2017
- Summaries of notable transactions from 2018 to 2019, such as:
- Danaher / Beckman Coulter Acquisitions in 2018 / 2019
- QIAGEN’s M&A Activity
- bioMérieux’s M&A Moves
- Illumina’s Acquisitions of PacBio and Edico Genome
- Summaries of notable transactions from 2016 to 2017, such as:
- Abbott’s Acquisitions, Divestures, and the Alere Deal
- Siemens’ Recent M&A Activity
- Konica Minolta’s Acquisitions of Ambry Genetics and Invicro
- Thermo Fisher’s Completion of the Patheon Acquisition
- Danaher’s Acquisition of Cepheid for Nearly $4 Billion
For further details and to purchase directly, please contact us.
Table of Contents
1: Executive Summary
The Market Landscape
- Overview
- Next-Generation Sequencing
- Cancer Testing (Liquid Biopsy)
- Companion Diagnostics
- The Clinical Laboratory Services Market
Mergers and Acquisitions of Some Major Market Players
- Roche
- Abbottís Molecular Diagnostics Business Post-Acquisition of Alere
- Danaher
- Siemens
- Thermo Fisher Scientific
Mergers and Acquisitions across Various Market Segments
- NGS Market Landscape Changing Fast
- Cancer Testing (Liquid Biopsy)
- Companion Diagnostics
- Immunohistochemistry (Immunoassay) Market
- Lab-Developed Test (LDT) Services Market
- The PCR/NAAT Market
- The Molecular Transplant Diagnostics Segment
Methodology
2: IVD Mergers and Acquisitions
Brief Overview: The IVD Industry
-
- Table 2-1: Selected Acquisitions of Diagnostic Companies, from 2018 to end June 2019
Selected 2018 / 2019 Acquisitions of Note
- Danaher / Beckman Coulter Acquisitions in 2018 / 2019
- Meridian Enters Syndromic with GenePOC Acquisition
- Thermo Fisher Acquires Provider of Mass Spectrometry Software
- QIAGEN M&A Activity
- PerkinElmer Acquires Cell Assay Company
- Charles River Labsí M&A Activity
- bioMÈrieux Active in M&A
- Eli Lilly acquires Loxo Oncology for $8 billion
- Luminex Completes Acquisition of MilliporeSigma’s Flow Cytometry Product Line
- OraSure Acquires CoreBiome and Novosanis
- Illumina Acquires PacBio, Edico Genome
- Agilent Active in M&A
- Recent Acquisitions by Quest
- Precision for Medicine Acquires ApoCell
- Bruker Acquires Majority Interest in Hain Lifescience, Infectious Disease-focused MDx Company
- Grifols Expands Its Plasma Collection Network
- Tecan Acquires NGS Company
- Myriad Genetics Acquires Counsyl
- Vela Diagnostics Buys Great Basin Scientific
- Celgene Active in Early 2018
- Early 2018 M&A Activity in Biotech — Sanofi Buys Bioverativ, Ablynx
Selected 2016 / 2017 Acquisitions of Note
-
- Table 2-2: Selected Acquisitions of Diagnostic Companies, 2016-2017
- Chembio Diagnostics Acquires Malaysian Firm RVR Diagnostics
- Abbott: Acquisitions, Divestures and the Alere Deal
- Konica Minolta Acquires Ambry Genetics and Invicro, Building a Presence in Precision Medicine
- Siemensí Activity in Recent Years
- Quidel Amends Alere Deal
- Thermo Completes Patheon Acquisition
- Agilent Acquires the Molecular and Sample Barcoding Patent Portfolios of Population Genetics
- Enterome and Nestle Health Science Form Microbiome Diagnostics Partners
- PerkinElmer Expansion via Tulip and Euroimmun Acquisitions
- Sysmex Acquires Oxford Gene Technology (OGT)
- LabCorp Completes PAML Acquisition
- Cathay Fortune International Acquires Molecular Diagnostics Firm Epigenomics
- Hologic Acquires Cynosure
- Bio-Rad Acquires ddPCR Developer RainDance
- Grifols Acquires NAT Donor Screening Unit from Hologic
- Johnson & Johnson Diabetes Business Attracts Chinese Interest
- Danaher Acquires Molecular Diagnostics Leader Cepheid for Nearly $4 Billion
- Abbott Acquires St. Jude Medical, Adds Patient Monitoring and Neurostimulation Strength
- Founding CTC Technology Finds Another Home
- Curetis Acquisitions: Real-Time qPCR-based Gyronimo Platform and Asset from Siemens Technology Accelerator
- Bruker Acquires Nucleic Acid Testing Assays and Syndromic Panel Technology
- LabCorp Completes Its Acquisition of Sequenom
- Bio-Techne Acquires Advanced Cell Diagnostics (ACD)
- Debiopharm Group Acquires GenePOC
- Luminex Acquires Nanosphereís Verigene Platform
- Quest and DiaSorin Focused on Key Markets Following 2016 Acquisition Deal
- Immucor Acquires Sirona Genomics
- Illumina Establishes GRAIL Bio
- Charles River Acquires Agilux and WIL Research
Related products
COVID-19 Testing Markets, 2023
May 18, 2023
As the COVID-19 pandemic evolves into an endemic phase, the landscape of COVID-19 testing is changing rapidly. Kalorama Information’s COVID-19 Testing Markets, 2023 report provides crucial insights into this shifting market, answering key questions and providing valuable market sizing and estimates.
Key Insights Provided:
- Market impacts and trends in the evolving COVID-19 testing…
$4,000.00 – $6,000.00
In Vitro Diagnostic (IVD) Trends and Market Update: November 2023
November 7, 2023
As in vitro diagnostic (IVD) testing returns to its vital role in healthcare, it remains a cornerstone in medical practice, providing crucial insights for physicians, from diagnosis to precision medicine. While COVID-19 testing sees a decline, it continues to influence total revenues for 2023. In this ever-changing landscape, characterized by new products, shifts in global…
$3,750.00 – $5,625.00
The Worldwide Market for Clinical Laboratory Services, 9th Edition
June 25, 2024
Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies…
$5,000.00 – $7,500.00
